LEAWOOD, Kan., July 10, 2018 /PRNewswire/ -- Aratana
Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company
focused on the licensing, development and commercialization of
innovative therapeutics for dogs and cats, will host a live
conference call on Friday, August 3,
2018 at 8:30 a.m. ET to
discuss financial results from the second quarter ended
June 30, 2018.
Interested participants and investors may access the audio
webcast or use the conference call dial-in:
1 (866) 364-3820 (U.S.)
1 (855) 669-9657 (Canada)
1 (412) 902-4210 (International)
A replay of the second quarter 2018 results teleconference will
be available the same day of the event by approximately
11 a.m. ET and an audio webcast will
be accessible for 90 days in the Aratana Investor Room. For a
replay of the call, use the below dial-in and conference ID
10122186:
1 (877) 344-7529 (U.S.)
1 (855) 669-9658 (Canada)
1 (412) 317-0088 (International)
About Aratana Therapeutics
Aratana Therapeutics is a
pet therapeutics company focused on licensing, developing and
commercializing innovative therapeutics for dogs and cats. As a
pioneer in pet therapeutics, Aratana's mission is to deliver safe
and effective therapeutics that elevate the standard of care in
veterinary medicine. We work with companion animal veterinarians to
bring new therapeutics to market that support the needs of pets and
their owners. For more information, please visit
www.aratana.com.
Contacts
For investor inquires:
Craig Tooman
ctooman@aratana.com
(913) 353-1026
For media inquiries:
Rachel
Reiff
rreiff@aratana.com
(913) 353-1050
View original content with
multimedia:http://www.prnewswire.com/news-releases/aratana-therapeutics-to-report-second-quarter-2018-financial-results-300677952.html
SOURCE Aratana Therapeutics